PMC:7283670 / 107421-107605 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":35,"end":43},"obj":"Body_part"},{"id":"T11","span":{"begin":80,"end":88},"obj":"Body_part"},{"id":"T12","span":{"begin":95,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma67128"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma67128"}],"text":"Experimental: PD‐1 group\nAnti‐PD‐1 antibody, 200 mg, IV, one time\nExperimental: thymosin group\nThymosin, 1.6 mg sc qd, last for 5 days\nPlacebo comparator: control group stand treatment"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T23","span":{"begin":112,"end":114},"obj":"http://purl.obolibrary.org/obo/CLO_0008954"}],"text":"Experimental: PD‐1 group\nAnti‐PD‐1 antibody, 200 mg, IV, one time\nExperimental: thymosin group\nThymosin, 1.6 mg sc qd, last for 5 days\nPlacebo comparator: control group stand treatment"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5320","span":{"begin":14,"end":16},"obj":"Chemical"},{"id":"T71040","span":{"begin":19,"end":24},"obj":"Chemical"},{"id":"T42282","span":{"begin":30,"end":32},"obj":"Chemical"},{"id":"T9670","span":{"begin":53,"end":55},"obj":"Chemical"},{"id":"T65756","span":{"begin":89,"end":94},"obj":"Chemical"},{"id":"T67187","span":{"begin":163,"end":168},"obj":"Chemical"}],"attributes":[{"id":"A17449","pred":"chebi_id","subj":"T5320","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"},{"id":"A5860","pred":"chebi_id","subj":"T71040","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A65351","pred":"chebi_id","subj":"T42282","obj":"http://purl.obolibrary.org/obo/CHEBI_74756"},{"id":"A83729","pred":"chebi_id","subj":"T9670","obj":"http://purl.obolibrary.org/obo/CHEBI_74327"},{"id":"A10914","pred":"chebi_id","subj":"T65756","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A21136","pred":"chebi_id","subj":"T67187","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Experimental: PD‐1 group\nAnti‐PD‐1 antibody, 200 mg, IV, one time\nExperimental: thymosin group\nThymosin, 1.6 mg sc qd, last for 5 days\nPlacebo comparator: control group stand treatment"}

{"project":"LitCovid-sentences","denotations":[{"id":"T915","span":{"begin":25,"end":65},"obj":"Sentence"},{"id":"T916","span":{"begin":66,"end":94},"obj":"Sentence"},{"id":"T917","span":{"begin":95,"end":134},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Experimental: PD‐1 group\nAnti‐PD‐1 antibody, 200 mg, IV, one time\nExperimental: thymosin group\nThymosin, 1.6 mg sc qd, last for 5 days\nPlacebo comparator: control group stand treatment"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2050","span":{"begin":30,"end":34},"obj":"Gene"},{"id":"2051","span":{"begin":14,"end":18},"obj":"Gene"}],"attributes":[{"id":"A2050","pred":"tao:has_database_id","subj":"2050","obj":"Gene:6622"},{"id":"A2051","pred":"tao:has_database_id","subj":"2051","obj":"Gene:6622"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Experimental: PD‐1 group\nAnti‐PD‐1 antibody, 200 mg, IV, one time\nExperimental: thymosin group\nThymosin, 1.6 mg sc qd, last for 5 days\nPlacebo comparator: control group stand treatment"}